THERAPY IV KELARE HEAVY METAL DMPS
DMPS is widely recognized as an antidote for a range of metal intoxications. In Germany, it is widely used as an effective diagnosis and antidote in the treatment of chronic metal exposure.
There is widespread medical recognition that DMPS is effective in accelerating metal excretion without severe side effects in acute and chronic intoxication with inorganic and organic mercury, bismuth, arsenic and chronic lead poisoning. Other types stick to metals, such as Mercury, Arsenic, Lead, Zinc and Copper.
Price: 900 RON - 250 mg (5 ml)
Special offer 1: 16% DISCOUNT for a package of 5 IV / IM therapies
Special offer 2: 25% DISCOUNT for 5 vitamins / minerals in one administration
DMPS is sometimes prescribed by doctors to clean toxic metals, such as mercury, arsenic, lead, zinc and copper, from the blood. Doctors have used the molecule for decades to treat heavy metal poisoning. In these cases it is administered through an IV.
The metabolism of DMPS, being hydrophilic in nature, has been thoroughly studied. DMPS undergoes both renal and biliary excretion and is excreted largely through the urine.
DMPS is distributed in both an intracellular and extracellular manner. DMPS does not cross the blood brain barrier and does not re-distribute arsenic, lead or inorganic mercury to the brain. Adverse reactions are known but are relatively rare.
About 90% of DMPS is eliminated via the kidneys. After 24h about 80% of the dose received has been excreted. DMPS does not accumulate in tissue even after repeated use.
Since the kidneys are the main organs of excretion for DMPS and its complexes, patients with a limited kidney function should not be chelated with this antidote if serum creatinine values exceed 2.5mg/dl. Animal studies on the acute and chronic toxicity of DMPS have been carried out and results illustrate the safety of this agent and its wide therapeutic window. DMPS is not mutagenic and seems to have no teratogenic effects. It is not carcinogenic.